P1519: EXPLORING THE ROLE OF FGF23 IN BETA-THALASSEMIA: A NOVEL THERAPEUTIC TARGET TO AMELIORATE ALTERED INTERACTIONS BETWEEN HSC AND BONE MARROW NICHE

• L. Raggi,
• A. Aprile,
• S. Bolamperti,
• I. Villa,
• M. Storto,
• G. Morello,
• S. Marktel,
• C. Tripodo,
• M. D. Cappellini,
• I. Motta,
• A. Rubinacci,
• G. Ferrari

Affiliations

L. Raggi

1 San Raffaele-Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute

A. Aprile

1 San Raffaele-Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute

S. Bolamperti

2 Bone Metabolism Unit, Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, Milan

I. Villa

2 Bone Metabolism Unit, Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, Milan

M. Storto

1 San Raffaele-Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute

G. Morello

3 Tumor Immunology Unit, Human Pathology Section, Department of Health Sciences, University of Palermo, Palermo

S. Marktel

4 Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute

C. Tripodo

3 Tumor Immunology Unit, Human Pathology Section, Department of Health Sciences, University of Palermo, Palermo

M. D. Cappellini

5 UOC General Medicine, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico

I. Motta

5 UOC General Medicine, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico

A. Rubinacci

2 Bone Metabolism Unit, Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, Milan

G. Ferrari

1 San Raffaele-Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute